1. No category

A Seminar jointly hosted by the
UCL Cancer Institute
and
UCL School of Pharmacy Drug Discovery Cluster
Dr Tim Somervaille
Cancer Research UK Manchester Institute
LSD for AML? Therapeutic targeting of epigenetic
modifiers in haematological malignancies.
Wednesday 29th October 2014
at
John Hanbury Lecture Theatre, 4.00pm
UCL School of Pharmacy, 29/39 Brunswick Square
Followed by a Reception from 5.00 – 6.30pm
UCL School of Pharmacy Square Lounge
All members of staff are welcome to attend
http://www.ucl.ac.uk/cancer
http://www.ucl.ac.uk/pharmacy/research/drug-discovery